The purpose of the studies is to evaluate the efficacy and safety of eloralintide in participants with moderate-to-severe obstructive sleep apnea and obesity or overweight.

Study testing a new oral medication for bronchiectasis to reduce flare-ups and improve symptoms.

The study aims to determine whether an inhalant medication can delay or reduce lung flare‑ups, improve quality of life, and remain safe and well tolerated.

This study is testing different doses of a new medication to see how safe it is and how well it works compared to a placebo in people with moderate to very severe COPD.

A study evaluating the efficacy, safety, and tolerability of a new drug in adults with inadequately controlled Chronic Obstructive Pulmonary Disease (COPD).

A clinical research study to evaluate an investigational drug as an add-on treatment for Chronic Obstructive Pulmonary Disease (COPD)

BUS-P3-02 / CALM-2 Study

A Phase 2a, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fexlamose (AER-01) Inhalation Solution in the Treatment of Adults with Moderate to Severe Chronic Obstructive Pulmonary Disease